NRX Pharmaceuticals, Inc. · Brief

Next report

12 days

Nov 16 · after closeest.Q3 FY26

Expected move

±38.5%implied · report alone

1.383.10

straddle ±39.8%

spot 2.24exp Nov 20ATM strike 2ATM straddle 1.05IV 287%

Nov 3 closereport share · term structure

Expected move

—≥ implied

Q2 FY26±34.2%▲+4.89%×0.14

quarterimplied−35%0+35%realized×

Q2 FY26±34.2%▲+4.89%×0.14

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 16 report · est.

Bull2 of 3

+60.71%change in shares held by the largest reporting managers over the latest quarter13F · Jun 30 '26

48managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

8managers holding the bulk of reported value13F · Jun 30 '26

2 of 18largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Oct 7 '26once per report · top 2 per case

NRXP report session

No linked exposure.

Nov 2impliedImplied move: ±30.4% into Nov 16 earnings (Nov 2 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.